SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anavex Life Sciences Corp. – ‘10-K’ for 9/30/15 – ‘ZIP’

On:  Tuesday, 12/29/15, at 8:11am ET   ·   For:  9/30/15   ·   Accession #:  1615774-15-3756   ·   File #:  1-37606

Previous ‘10-K’:  ‘10-K’ on 12/29/14 for 9/30/14   ·   Next:  ‘10-K’ on 12/14/16 for 9/30/16   ·   Latest:  ‘10-K’ on 11/27/23 for 9/30/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/29/15  Anavex Life Sciences Corp.        10-K        9/30/15   73:5M                                     S2 Filings LLC/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    573K 
 2: EX-10.91    Material Contract                                   HTML    124K 
 3: EX-10.92    Material Contract                                   HTML     79K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     19K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
14: R1          Document and Entity Information                     HTML     50K 
15: R2          Consolidated Balance Sheets                         HTML     68K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     30K 
17: R4          Consolidated Statements of Operations               HTML     68K 
18: R5          Consolidated Statements of Cash Flows               HTML     93K 
19: R6          Consolidated Statement of Changes in Stockholders'  HTML    112K 
                Equity                                                           
20: R7          Consolidated Statement of Changes in Stockholders'  HTML     33K 
                Equity (Parenthetical)                                           
21: R8          Business Description and Basis of Presentation      HTML     28K 
22: R9          Summary of Significant Accounting Policies          HTML     95K 
23: R10         Equipment                                           HTML     36K 
24: R11         Promissory Notes Payable                            HTML     37K 
25: R12         Deferred Grant Income                               HTML     25K 
26: R13         Non-interest Bearing Liabilities                    HTML     86K 
27: R14         Capital Stock                                       HTML     39K 
28: R15         Lincoln Park Purchase Agreement                     HTML     33K 
29: R16         Related Party Transactions                          HTML     36K 
30: R17         Commitments                                         HTML    105K 
31: R18         Income Taxes                                        HTML     54K 
32: R19         Supplemental Cash Flow Information                  HTML     29K 
33: R20         Subsequent Events                                   HTML     27K 
34: R21         Summary of Significant Accounting Policies          HTML    123K 
                (Policies)                                                       
35: R22         Summary of Significant Accounting Policies          HTML     38K 
                (Tables)                                                         
36: R23         Equipment (Tables)                                  HTML     33K 
37: R24         Promissory Notes Payable (Tables)                   HTML     30K 
38: R25         Non-interest Bearing Liabilities (Tables)           HTML     76K 
39: R26         Commitments (Tables)                                HTML    103K 
40: R27         Income Taxes (Tables)                               HTML     51K 
41: R28         Business Description and Basis of Presentation      HTML     28K 
                (Details Narrative)                                              
42: R29         Summary of Significant Accounting Policies          HTML     31K 
                (Details Narrative)                                              
43: R30         Summary of Significant Accounting Policies          HTML     31K 
                (Details)                                                        
44: R31         Summary of Significant Accounting Policies          HTML     36K 
                (Details 1)                                                      
45: R32         Equipment (Details)                                 HTML     31K 
46: R33         Promissory Notes Payable (Details Narrative)        HTML     43K 
47: R34         Promissory Notes Payable (Details)                  HTML     43K 
48: R35         Deferred Grant Income (Details Narrative)           HTML     24K 
49: R36         Non-interest Bearing Liabilities (Details           HTML    110K 
                Narrative)                                                       
50: R37         Non-interest Bearing Liabilities (Details)          HTML     25K 
51: R38         Non-interest Bearing Liabilities (Details 1)        HTML     33K 
52: R39         Non-interest Bearing Liabilities (Details 2)        HTML     35K 
53: R40         Non-interest Bearing Liabilities (Details 3)        HTML     37K 
54: R41         Non-interest Bearing Liabilities (Details 4)        HTML     32K 
55: R42         Non-interest Bearing Liabilities (Details 5)        HTML     32K 
56: R43         Non-interest Bearing Liabilities (Details 6)        HTML     31K 
57: R44         Capital Stock (Details Narrative)                   HTML     96K 
58: R45         Lincoln Park Purchase Agreement (Details            HTML     48K 
                Narrative)                                                       
59: R46         Related Party Transactions (Details Narrative)      HTML     68K 
60: R47         Commitments (Details Narrative)                     HTML     54K 
61: R48         Commitments (Details Narrative 1)                   HTML     50K 
62: R49         Commitments (Details)                               HTML     44K 
63: R50         Commitments (Details 1)                             HTML     40K 
64: R51         Commitments (Details 2)                             HTML     47K 
65: R52         Commitments (Details 3)                             HTML     78K 
66: R53         Income Taxes (Details Narrative)                    HTML     24K 
67: R54         Income Taxes (Details)                              HTML     43K 
68: R55         Income Taxes (Details 1)                            HTML     50K 
69: R56         Supplemental Cash Flow Information (Details         HTML     40K 
                Narrative)                                                       
70: R57         Subsequent Events (Details Narrative)               HTML     32K 
72: XML         IDEA XML File -- Filing Summary                      XML    126K 
71: EXCEL       IDEA Workbook of Financial Reports                  XLSX     81K 
 8: EX-101.INS  XBRL Instance -- avxl-20150930                       XML   1.42M 
10: EX-101.CAL  XBRL Calculations -- avxl-20150930_cal               XML    130K 
11: EX-101.DEF  XBRL Definitions -- avxl-20150930_def                XML    590K 
12: EX-101.LAB  XBRL Labels -- avxl-20150930_lab                     XML    946K 
13: EX-101.PRE  XBRL Presentations -- avxl-20150930_pre              XML    787K 
 9: EX-101.SCH  XBRL Schema -- avxl-20150930                         XSD    168K 
73: ZIP         XBRL Zipped Folder -- 0001615774-15-003756-xbrl      Zip    128K 


‘ZIP’   —   XBRL Zipped Folder — 0001615774-15-003756-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:avxl-20150930.xml
avxl-20150930.xsd
avxl-20150930_cal.xml
avxl-20150930_def.xml
avxl-20150930_lab.xml
avxl-20150930_pre.xml


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/27/23  Anavex Life Sciences Corp.        10-K        9/30/23   54:5.7M                                   Electro Filings LLC/FA
 1/27/23  Anavex Life Sciences Corp.        10-K/A      9/30/22    4:308K                                   Electro Filings LLC/FA
11/28/22  Anavex Life Sciences Corp.        10-K        9/30/22   49:5.1M                                   Electro Filings LLC/FA
11/24/21  Anavex Life Sciences Corp.        10-K        9/30/21   50:13M                                    Electro Filings LLC/FA
12/28/20  Anavex Life Sciences Corp.        10-K        9/30/20   44:3.6M                                   Electro Filings LLC/FA
Top
Filing Submission 0001615774-15-003756   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 4:35:36.1pm ET